Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.035
+0.035 (3.50%)
At close: Dec 5, 2025, 4:00 PM EST
1.080
+0.045 (4.39%)
After-hours: Dec 5, 2025, 7:47 PM EST
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $6.13 million as of December 5, 2025. Its market cap has increased by 83.63% in one year.
Market Cap
6.13M
Enterprise Value
-6.58M
1-Year Change
83.63%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $6.13M, a decrease of -93.23%. That is a compound annual growth rate of -41.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 6.13M | 59.16% |
| Dec 31, 2024 | 3.85M | 22.18% |
| Dec 29, 2023 | 3.15M | -29.38% |
| Dec 30, 2022 | 4.46M | -93.27% |
| Dec 31, 2021 | 66.32M | -28.84% |
| Dec 31, 2020 | 93.20M | 2.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |